Eddie Fridman
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 4
- Cancer Research top 5%
- Obstetrics and Gynecology top 5%
- Molecular Biology top 5%
- Renal and related cancers 16
-
- Renal cell carcinoma treatment 11
-
- Bladder and Urothelial Cancer Treatments 7
- Testicular diseases and treatments 4
-
- Urologic and reproductive health conditions 6
- Soft tissue tumor case studies 4
-
- Cancer Cells and Metastasis 5
- Co-authors
- Dror MeirowDor JGideon RechaviE. SchiffHila RaananiJacob KorachGilad Ben‐BaruchJozef Škarda
- Journals
- Science (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- IsraelUnited StatesCzechia
In The Last Decade
Eddie Fridman
71 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 111
- Reproductive Medicine 603
- Cancer Research 432
- Obstetrics and Gynecology 209
- Public Health, Environmental and Occupational Health 640
- Molecular Biology 1.5k
Countries citing papers authored by Eddie Fridman
This map shows the geographic impact of Eddie Fridman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie Fridman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie Fridman more than expected).
Fields of papers citing papers by Eddie Fridman
This network shows the impact of papers produced by Eddie Fridman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie Fridman. The network helps show where Eddie Fridman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eddie Fridman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 4 | |
| 3 | 2018 | 0 | |
| 4 | 2012 | 4 | |
| 5 | 2012 | 3 | |
| 6 | 2010 | 4 | |
| 7 | 2010 | 20 | |
| 8 | Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. | 2009 | 33 |
| 9 | 2009 | 34 | |
| 10 | 2009 | 112 | |
| 11 | 2008 | 64 | |
| 12 | 2007 | 244 | |
| 13 | 2007 | 35 | |
| 14 | 2007 | 91 | |
| 15 | 2006 | 7 | |
| 16 | 2006 | 44 | |
| 17 | 2005 | 7 | |
| 18 | 2005 | 39 | |
| 19 | 2004 | 35 | |
| 20 | 2002 | 12 |
About Eddie Fridman
Eddie Fridman is a scholar working on Reproductive Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 74 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal and related cancers (16 papers), Renal cell carcinoma treatment (11 papers), Bladder and Urothelial Cancer Treatments (7 papers), Urologic and reproductive health conditions (6 papers), Cancer Cells and Metastasis (5 papers), Soft tissue tumor case studies (4 papers), Testicular diseases and treatments (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Reproductive Medicine (603 citations), Cancer Research (432 citations) and Obstetrics and Gynecology (209 citations). Eddie Fridman has collaborated with scholars based in Israel, United States and Czechia. Frequent co-authors include Dror Meirow, Dor J, Gideon Rechavi, E. Schiff, Hila Raanani, Jacob Korach, Gilad Ben‐Baruch, Jozef Škarda, Jacob Levron and Ninette Amariglio. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.